Singapore markets close in 58 minutes

BioCryst Pharmaceuticals, Inc. (BCRX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
11.44-0.43 (-3.62%)
At close: 04:00PM EST
11.45 +0.01 (+0.09%)
After hours: 07:58PM EST
Currency in USD
Earnings estimateCurrent qtr. (Dec 2021)Next qtr. (Mar 2022)Current year (2021)Next year (2022)
No. of analysts1231112
Avg. Estimate-0.31-0.32-1.22-1
Low estimate-0.38-0.38-1.31-1.42
High estimate-0.21-0.25-1.01-0.5
Year ago EPS-0.34-0.36-1.09-1.22
Revenue estimateCurrent qtr. (Dec 2021)Next qtr. (Mar 2022)Current year (2021)Next year (2022)
No. of analysts1021011
Avg. Estimate48.05M44.57M157.67M226.83M
Low estimate40.5M39.95M152M167M
High estimate56.54M49.2M166.55M294.2M
Year ago sales4.02M8.89M17.81M157.67M
Sales growth (year/est)1,096.50%401.30%785.20%43.90%
Earnings history30/12/202030/03/202129/06/202129/09/2021
Est. EPS-0.25-0.27-0.24-0.29
Actual EPS-0.34-0.36-0.24-0.33
Difference-0.09-0.090-0.04
Surprise %-36.00%-33.30%0.00%-13.80%
EPS trendCurrent qtr. (Dec 2021)Next qtr. (Mar 2022)Current year (2021)Next year (2022)
Current estimate-0.31-0.32-1.22-1
7 days ago-0.31-0.32-1.23-1
30 days ago-0.27-0.24-1.15-0.79
60 days ago-0.27-0.24-1.16-0.72
90 days ago-0.27-0.24-1.16-0.74
EPS revisionsCurrent qtr. (Dec 2021)Next qtr. (Mar 2022)Current year (2021)Next year (2022)
Up last 7 days1N/A1N/A
Up last 30 days3N/A22
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/A2
Growth estimatesBCRXIndustrySector(s)S&P 500
Current qtr.8.80%N/AN/AN/A
Next qtr.11.10%N/AN/AN/A
Current year-11.90%N/AN/AN/A
Next year18.00%N/AN/AN/A
Next 5 years (per annum)17.60%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A